Thomas Kuhn
About
Thomas studied pharmacy in Saarbrücken until 2017 and is working on his PhD project in the Biogenic Nanotherapeutics group since 2018. His research interests include membrane vesicles derived from probiotic bacteria and eukaryotic cells in the context of novel anti-inflammatory therapeutic options. His work is funded by the Studienstiftung des Deutschen Volkes.
2023
Ageing-associated small RNA cargo of extracellular vesicles
Kern F, Kuhn T, Ludwig N, Simon M, Gröger L, Fabis N, Aparicio-Puerta E, Salhab A, Fehlmann T, Hahn O, …, Laschke M, Keller A (2023)
RNA biology 20 (1): 482-494DOI: 10.1080/15476286.2023.2234713
2022
The inherent antibiotic activity of myxobacteria-derived autofluorescent outer membrane vesicles is switched on and off by light stimulation
Lapuhs P, Heinrich E, Garcia R, Goes A, Frank N, Bollenbach L, Stibane V, Kuhn T, Koch M, Kiemer A, …, Fuhrmann K, Fuhrmann G (2022)
NanoscaleDOI: 10.1039/d2nr02743g
2021
Stimulation of Probiotic Bacteria Induces Release of Membrane Vesicles with Augmented Anti-inflammatory Activity
Müller L, Kuhn T, Koch M, Fuhrmann G (2021)
ACS Appl. Bio Mater.DOI: 10.1021/acsabm.0c01136
2020
Myxobacteria-Derived Outer Membrane Vesicles: Potential Applicability Against Intracellular Infections
Goes A, Lapuhs P, Kuhn T, Schulz E, Richter R, Panter F, Dahlem C, Koch M, Garcia R, Kiemer A, Müller R, Fuhrmann G (2020)
Cells 9 (1)DOI: 10.3390/cells9010194
Probiomimetics-Novel Lactobacillus-Mimicking Microparticles Show Anti-Inflammatory and Barrier-Protecting Effects in Gastrointestinal Models
Kuhn T, Koch M, Fuhrmann G (2020)
Small (Weinheim an der Bergstrasse, Germany) 16 (40)DOI: 10.1002/smll.202003158